Calliditas Therapeutics AB (publ)
CALT
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 75.22M | 75.79M | 96.82M | 72.21M | 80.29M |
| Total Receivables | 21.00M | 17.10M | 18.71M | 11.98M | 13.57M |
| Inventory | 3.79M | 2.74M | 2.03M | 1.47M | 1.64M |
| Prepaid Expenses | 8.91M | 7.15M | 3.38M | 9.41M | 7.73M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 5.85M | -100.00 | 100.00 |
| Total Current Assets | 108.92M | 102.78M | 126.80M | 95.07M | 103.22M |
|
|
|||||
| Total Current Assets | 108.92M | 102.78M | 126.80M | 95.07M | 103.22M |
| Net Property, Plant & Equipment | 5.60M | 6.12M | 5.39M | 5.09M | 3.85M |
| Long-term Investments | 4.51M | 4.48M | 4.83M | -- | -- |
| Goodwill | 4.51M | 4.48M | 4.83M | -- | -- |
| Total Other Intangibles | 39.99M | 39.68M | 42.83M | 43.73M | 47.74M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.82M | 4.86M | 5.02M | 4.02M | 3.62M |
| Total Assets | 164.85M | 157.90M | 184.88M | 147.91M | 158.43M |
|
|
|||||
| Total Accounts Payable | 14.25M | 9.48M | 10.00M | 6.16M | 6.68M |
| Total Accrued Expenses | 23.79M | 25.57M | 27.90M | 23.09M | 17.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 1.25M | -- | -- |
| Total Finance Division Other Current Liabilities | 2.51M | 3.12M | 1.33M | 2.38M | 2.85M |
| Total Other Current Liabilities | 2.51M | 3.12M | 1.33M | 2.38M | 2.85M |
| Total Current Liabilities | 40.55M | 38.17M | 40.48M | 31.63M | 26.91M |
|
|
|||||
| Total Current Liabilities | 40.55M | 38.17M | 40.48M | 31.63M | 26.91M |
| Long-Term Debt | 92.70M | 92.25M | 93.42M | 67.97M | 70.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.43M | 2.83M | 2.69M | 2.70M | 1.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.09M | 13.41M | 14.99M | 13.27M | 12.50M |
| Total Liabilities | 154.77M | 146.66M | 151.58M | 115.57M | 111.67M |
|
|
|||||
| Common Stock & APIC | 226.20K | 222.90K | 263.07M | 218.70K | 220.90K |
| Retained Earnings | -- | -- | -229.26M | -- | -- |
| Treasury Stock & Other | 9.85M | 11.01M | -520.20K | 32.12M | 46.53M |
| Total Common Equity | 10.08M | 11.24M | 33.29M | 32.34M | 46.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.08M | 11.24M | 33.29M | 32.34M | 46.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.08M | 11.24M | 33.29M | 32.34M | 46.75M |
|
|
|||||
